Brain scan reveals cognitive deficits in older 'cognitively normal' individuals living with HIV
News Nov 19, 2015
Neuroscientists at Georgetown University Medical Center have found in a small study that although a group of older individuals living with HIV scored “cognitively normal” in standard neuropsychology testing, a scan of their brains tells a different story.
Published in the journal AIDS Care, functional MRI (fMRI) scans, taken while participants were performing an alternating face-gender/word-semantic task, revealed that HIV-positive individuals in the study showed deficits in cognitive functioning, compared to an age matched HIV-negative controls.
Despite advances in treatment, HIV-associated neurocognitive disorder, or HAND, remains one of most common disorders in individuals diagnosed with HIV. Previous studies have suggested about 30 to 60 percent of individuals with HIV are affected, says neuroscientist Xiong Jiang, PhD, the lead author of the new study. This study suggests that cognitive impairments in those individuals with HIV aged 50 years or older might be even more prevalent than previously proposed.
“This could be due to the fact that some standard neuropsychology tests might be insensitive to HAND,” says Jiang. The new study used an experimental design that has been validated to study cognitive control (the ability to guide thought and action in accordance with current goals in a given environment) in healthy younger adults.
During the scanning, the participants were cued (unpredictably) to judge the gender of the face (male versus female) or the meaning of the word (e.g., animate for “tiger” and inanimate for “table”) on superimposed face-word images. A switch (after the cue) in task often leads to an increase in reaction time and a decrease in accuracy (known as switching cost).
The HIV-positive group was significantly slower in adjusting to change in tasks, which correlates with brain dysfunctions in the dorsal anterior cingulate cortex (dACC), one of the key executive regions. This collar-shaped area is near the front of the brain, and damage to this region has been linked to many cognitive impairments, including executive deficits and apathy.
“Intriguingly, both impairments are highly prevalent in individuals with HIV-infection, suggesting dACC might be one of commonly affected brain regions in HIV and a potential neural target for therapies,” says Jiang.
“These findings, although preliminary, could have a significant implication for public health,” says Jiang, “While there is no proven treatment that can effectively treat HAND other than control HIV replication, it is important for caregivers, families and the individuals themselves to know if they are affected.”
Jiang says he will now study HAND in a larger population—research supported by a $2 million grant from the National Institute of Mental Health—to further develop his fMRI-based biomarkers with the potential to guide and evaluate early and targeted therapies.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Jiang X et al. Behavioral and neuroimaging evidence for impaired executive function in “cognitively normal” older HIV-infected adults. AIDS Care, Published Online November 17 2015. doi: 10.1080/09540121.2015.1112347
Early Life Experiences Alter DNA Structure in the Adult BrainNews
Scientists report in the journal Science that the type of mothering a female mouse provides her pups actually changes their DNA.READ MORE
Worms Exhibit Fear and Respond to Anti-anxiety MedsNews
A team of investigators has uncovered new clues about the mechanisms of fear and anxiety through an unlikely creature: the tiny nematode worm.READ MORE
Vegetable Compound Could Have a Key Role in ‘Beeting’ Alzheimer’s DiseaseNews
A compound in beets that gives the vegetable its distinctive red color could eventually help slow the accumulation of misfolded proteins in the brain, a process that is associated with Alzheimer’s disease.READ MORE
Comments | 0 ADD COMMENT
International Conference on Neuroimmunology, Neurological disorders and Neurogenetics
Sep 26 - Sep 27, 2018